• Profile

Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment—Analyses from the German clinical RCC-Registry

Urologic Oncology: Seminars and Original Investigations Aug 23, 2018

Goebell PJ, et al. - In patients being treated for metastatic renal cell carcinoma (mRCC) in Germany, authors evaluated the prognostic impact of body mass index (BMI). As per data, high BMI was significantly and independently associated with longer OS in a prospective German cohort of mRCC routine patients starting first-line systemic treatment. They noted an independent association of Memorial Sloan Kettering Cancer Center risk factors with shorter OS.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen